Spanish 
Chinese 
Russian 
German 
French 
Japanese 
Portuguese 
Hindi Clinical Oncology: Case Reports
Xin-Hua Cao Author
Subjects of specialization
Affiliation
Molecular Biology ,Thoracic Cancer,Tumor,Ovarian Cancer,Breast cancer
Breast Disease Center, Zhongda Hospital, Southeast University, 87# Dingjia Qiao, Nanjing 210009, China
Biography
Dr. Xin-Hua Cao, is working as a Research Scientisit and professor at Breast Disease Center, Zhongda Hospital, Southeast University, 87# Dingjia Qiao, Nanjing 210009, China. Dr. Cao specializes in Molecular Biology , Thoracic Cancer, Tumor, Breast cancer.
Publications
Review Article Open Access
The Progressive Journey from Ductal Carcinoma in situ into Invasive Breast Cancer: An Extensive Systematic Literature Review on Biomarkers
Author(s): Ercilia Da Gloria LI, Jian-Xin Lv, Guy-Armel Bounda, Xin-Hua Cao, Hao-Lin Hu and Ya-Nan Zhang* (China)
Breast Cancer (BC) is the most common cancer in women, and second most cancer worldwide. It is a progressive and fatal disease that affects women of all ages, and is divided into several subtypes with distinct histological, genomic and transcriptomic profiles, outcomes, and responses to therapy. Ductal carcinoma in situ (DCIS) is a pre-invasive stage in the development of invasive breast carcinoma. DCIS presents a clinical problem, with high risk of potential progressive disease. A subset of patients with ductal carcinoma in situ (DCIS) will develop Invasive Breast Cancer (IBC). Thus, biomarkers are pivotal important to help identify DCIS/ IBC genes that might probably lead to potential rational treatment therapies. While biomarkers are defined as indicators of normal biological process... view more»